On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-TheWire.in * The Parliamentary standing committee on chemicals and fertilisers has produced a report highlighting gaps in the availability of COVID-19 drugs and devices during the pandemic. * The committee has asked the national government why PSUs didn’t receive licenses to make COVID drugs when private manufacturers did. * The MPs on the committee also spotlighted widespread irrational drug use in COVID-19 management, despite the existence of a standard treatment protocol. New Delhi: The...

-PTI/ NDTV.com The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a campaign launched by the Department of Pharmaceuticals to provide quality medicines at affordable prices to the masses New Delhi: Prime Minister Narendra Modi said the poor and the middle class have benefitted from the 'Jan Aushadhi Kendras', set up to provide generic drugs at affordable prices, and they saved about ₹ 13,000 crore through the stores. He also interacted with 'Jan Aushadhi...

Scientific knowledge has immensely helped in combating the dreadful coronavirus and its spread. Within a record short period of time, scientists (including virologists, epidemiologists, biostatisticians, etc.) and their research outputs helped the commoners to learn more about the SARS-CoV-2 and how it spreads from one individual to the next one. Common people have now come to know how simple techniques and behavioural change like the wearing of N95 masks, maintaining...

-The Hindu Gross domestic expenditure on research has stayed at 0.7% of the GDP for years While India has made ‘solid progress’ towards the Sustainable Development Goal (SDG) targets concerning industry, infrastructure and innovation, the country’s investment in research remains unsatisfactory, the UNESCO Science Report has observed. The gross domestic expenditure on research (GERD) has been stagnant at 0.7% of the GDP for years, although, in absolute terms, research expenditure has increased, the...